Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001554795-24-000123
Filing Date
2024-05-09
Accepted
2024-05-09 14:51:02
Documents
28
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q skin0506form10q.htm   iXBRL 10-Q 216030
2 EXHIBIT 31.1 skin0506form10qexh31_1.htm EX-31.1 8263
3 EXHIBIT 31.2 skin0506form10qexh31_2.htm EX-31.2 8282
4 EXHIBIT 32.1 skin0506form10qexh32_1.htm EX-32.1 3935
  Complete submission text file 0001554795-24-000123.txt   1060069

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE skin-20240331.xsd EX-101.SCH 8232
6 XBRL CALCULATION FILE skin-20240331_cal.xml EX-101.CAL 18093
7 XBRL DEFINITION FILE skin-20240331_def.xml EX-101.DEF 9602
8 XBRL LABEL FILE skin-20240331_lab.xml EX-101.LAB 92079
9 XBRL PRESENTATION FILE skin-20240331_pre.xml EX-101.PRE 64502
32 EXTRACTED XBRL INSTANCE DOCUMENT skin0506form10q_htm.xml XML 44579
Mailing Address 440 EAST 400 SOUTH STE 300 SALT LAKE CITY UT 84111
Business Address 440 EAST 400 SOUTH STE 300 SALT LAKE CITY UT 84111 801-323-2395
SKINOVATION PHARMACEUTICAL INC (Filer) CIK: 0001118072 (see all company filings)

EIN.: 870458170 | State of Incorp.: WY | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30991 | Film No.: 24929987
SIC: 6770 Blank Checks
(CF Office: 05 Real Estate & Construction)